Viewing Study NCT06551506


Ignite Creation Date: 2025-12-26 @ 2:43 PM
Ignite Modification Date: 2026-01-26 @ 11:38 AM
Study NCT ID: NCT06551506
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-22
First Post: 2024-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module